Hereditary macular dystrophy
MONDO:0020242Macular dystrophy that is related to a change in a gene.
Also known as: genetic macular dystrophy, genetic macular dystrophy (disease)
91 clinical trials for this condition and its sub-types, 3 tagged with Hereditary macular dystrophy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary macular dystrophy
-
Familial flecked retinopathy 0 trials · 45 incl. sub-types
5 sub-types
- Stargardt disease 35 trials · 36 incl. sub-types Sub-types →
- Bietti crystalline corneoretinal dystrophy 9 trials
- Fundus albipunctatus 1 trial Sub-types →
- Doyne honeycomb retinal dystrophy 0 trials
- Kandori fleck retina 0 trials
-
Macular corneal dystrophy 13 trials
-
Vitelliform macular dystrophy 6 trials · 10 incl. sub-types
2 sub-types
-
Cone dystrophy 4 trials
6 sub-types
- Cone dystrophy 3 0 trials
- Cone dystrophy 4 0 trials Sub-types →
- Cone dystrophy with supernormal rod response 0 trials
- Cone dystrophy, X-linked, with tapetal-like sheen 0 trials
- Retinal cone dystrophy 4 0 trials
- Retinal cone dystrophy type 1 0 trials
-
AICA-ribosiduria 1 trial
-
Macular dystrophy, retinal 1 trial
5 sub-types
- North Carolina macular dystrophy 0 trials
- Macular dystrophy, retinal, 3 0 trials
- Macular dystrophy, retinal, 4 0 trials
- Macular dystrophy, retinal, 5 0 trials
- Retinal macular dystrophy type 2 0 trials
-
EEM syndrome 0 trials
-
Coloboma of macula 0 trials
-
Macular dystrophy, X-linked 0 trials
-
Occult macular dystrophy 0 trials
-
5 sub-types
Most studied deeper sub-types
-
One-Time gene injection aims to halt rare blindness
Disease control Not yet recruitingThis trial tests a single injection of a gene therapy called ZVS101e for people with Bietti crystalline dystrophy, a rare inherited eye disease that leads to progressive vision loss. The therapy uses a harmless virus to deliver a working copy of the CYP4V2 gene to cells in the ey…
Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Gene therapy takes on rare eye disease in Second-Eye trial
Disease control Not yet recruitingThis study is for people with Bietti's crystalline dystrophy, a rare genetic eye disease that causes vision loss. They have already received the gene therapy VGR-R01 in one eye. Now, researchers want to test if giving the same treatment to the other eye is safe and can improve vi…
Phase 1/2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Smart contact lens could help those with vision loss see better
Symptom relief Not yet recruitingThis study tests a miniaturized smart contact lens in 32 people—some healthy, some with Stargardt's disease—to see if it is comfortable and easy to use. The lens tracks eye movements to help with vision tasks. Researchers will check for side effects and ask participants how they …
Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts • Aim: Symptom relief
Last updated Jun 26, 2026 18:34 UTC
-
Blindness may boost your sense of taste and smell, scientists say
Knowledge-focused Not yet recruitingThis study investigates whether people with central or peripheral vision loss develop heightened senses of taste and smell. Researchers will measure brain responses to sweet and vanilla flavors in 50 visually impaired adults and compare them to sighted controls. The goal is to un…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New eye camera could spot retinal disease earlier
Knowledge-focused Not yet recruitingThis study will test a new, noninvasive camera called XyCAM CRE that measures blood flow in the back of the eye. Researchers will compare its images with standard eye tests in 350 adults with retinal disorders. The goal is to see if this camera can provide extra information to he…
Sponsor: Stuart Terry Eye Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists track eye disease patterns to speed future cures
Knowledge-focused Not yet recruitingThis study looks back at medical records of 200 people with inherited retinal diseases, like retinitis pigmentosa and Stargardt disease. Researchers will analyze vision tests and eye scans to see how these diseases progress and how genetics affect symptoms. The goal is to find be…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New study aims to link eye scans with vision loss in macular dystrophy
Knowledge-focused Not yet recruitingThis study will look at 30 people with macular dystrophy to see how different eye tests—like OCT scans, mfERG, and standard vision tests—relate to each other. The goal is to better understand how these tests can track vision changes. No treatment is being tested; this is purely a…
Sponsor: New Valley University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:22 UTC